(Boursier.com) — Intrasense , specialist in medical imaging software solutions and designer of Myrian, presents its ambitions, its development plan for the year 2022 as well as the financial calendar for the 2022 financial year.
Driven by an innovation strategy and supported by the capital increase successfully carried out in June 2021, Intrasense is continuing its development plan. The company intends to increase its activity within its reference markets, Europe and China, in the fields of radiology and oncology.
The future line of Myra oncology products, a solution presented last June, is in the definition and development phase. The Intrasense teams are working in close collaboration with major clinical players in oncology, such as the I-SERIS group, on the definitions and functional validations of the future platform. Other major Research & Development partnerships are being finalized and will be communicated to the market in the coming weeks.
Myrian enriched with Artificial Intelligence (AI)
The Company continues to enrich the Myrian product range by providing radiologists with state-of-the-art clinical tools and expanded functionalities, in particular from Artificial Intelligence.
The integration of AI algorithms into the routine of clinicians, in a fluid workflow perfectly adapted to the needs of the user, is indeed at the heart of Intrasense’s vision.
In this context, new solutions such as those developed in partnership with the company MeVis to treat pulmonary pathologies, will be available in version 2.10 of Myrian. This new version will be subject to the new European regulation for medical devices in the first half of 2022 and marketed thereafter.
An ambitious growth target in Europe and China
Following the capital increase carried out in June 2021, Intrasense has implemented an ambitious development plan. The Group’s objective is to increase its market share in France, develop new markets in Europe and accelerate growth in China.
In this regard, new sales and marketing talents have joined Intrasense in recent months to support its growth momentum in the years to come. Geographic sales organisations, closer to customers, are being rolled out this year.
Increased visibility in 2022
This year, Intrasense will multiply the opportunities for meetings with imaging and oncology professionals.
The company’s teams will participate in the Arab Health congress which will take place at the World Trade Center in Dubai from January 24 to 27. This medical equipment show, the largest in the Middle East region, is an opportunity for Intrasense teams to expand the Group’s international presence.
The company will also be present at the China International Medical Equipment Fair (CMEF) congress to be held in Shanghai from April 7 to 10, 2022, allowing it to ensure visibility among healthcare and medical imaging professionals.
Finally, Intrasense will take part in several gatherings in France, such as the Journées Francophones de Scanner and the Journées Francophones de Radiologie next October.
Calendar of publication of annual results
Intrasense will announce its annual results for 2021 on March 10, 2022. The availability of the annual financial report for the year ended December 31, 2021 is planned for April 20, 2022.